SELLAS Life Sciences: The Ownership Structure Has Changed Before The Defining Catalyst
· seekingalpha.com
SELLAS Life Sciences heads into pivotal REGAL readout with rising institutional ownership, $138M cash runway, and shifting holders. See why SLS stock is a Buy.
I am an independent investor with more than 15 years of experience researching public companies, with a primary focus on identifying misunderstood businesses wh...